TMS Co., Ltd. (TYO:4891)
Japan · Delayed Price · Currency is JPY 99.00
0.00 (0.00%)
Aug 6, 2026, 3:01 PM JST
TMS Co., Ltd. Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
4.51B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Feb 28, 2025 | - | - | - |
| Feb 29, 2024 | - | - | - |
| Feb 28, 2023 | - | - | - |
| Feb 28, 2022 | 1.95B | - | - |
| Feb 28, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Transgenic Group | 13.17B |
| Kohjin Bio | 4.94B |
| Soiken Holdings | 4.40B |
| CellSource | 3.67B |
| PRISM BioLab Co.,LTD | 711.65M |
| Chiome Bioscience | 601.75M |
| D. Western Therapeutics Institute | 305.97M |
| Cyfuse Biomedical K.K. | 234.00M |